This compound is a protected cysteine derivative featuring a pyrrolidine ring with a dimethylcarbamoyl group and a benzoylthio ester. It is primarily used as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 141818-73-7
1-Pyrrolidinecarboxylic acid, 2-[[[(3-chloro-2-pyrazinyl)methyl]amino]carbonyl]-, phenylmethyl ester, (2S)-
pharmaceutical intermediate
3-Acetylpyridine N-oxide
pharmaceutical intermediate
N-Fmoc-S-(4-methoxybenzyl)-L-cysteine
pharmaceutical intermediate
Benzoic acid, 2,5-diiodo-
pharmaceutical intermediate
prop-2-enyl (2S,4S)-4-benzoylsulfanyl-2-(dimethylcarbamoyl)pyrrolidine-1-carboxylate
HOCDRPVUJNMBCM-GJZGRUSLSA-N
CN(C)C(=O)[C@@H]1C[C@@H](CN1C(=O)OCC=C)SC(=O)C2=CC=CC=C2
—